Development and characterization of a long-acting nanoformulated abacavir prodrug

AIM: A myristoylated abacavir (ABC) prodrug was synthesized to extend drug half-life and bioavailability. METHODS: Myristoylated ABC (MABC) was made by esterifying myristic acid to the drug's 5-hydroxy-cyclopentene group. Chemical composition, antiretroviral activity, cell uptake and retention...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Nanomedicine (Lond)
Päätekijät: Singh, Dhirender, McMillan, JoEllyn, Hilaire, James, Gautam, Nagsen, Palandri, Diana, Alnouti, Yazen, Gendelman, Howard E, Edagwa, Benson
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4996153/
https://ncbi.nlm.nih.gov/pubmed/27456759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2016-0164
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia